4//SEC Filing
O'Loughlin Steve 4
Accession 0001213900-18-009315
CIK 0001388320other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:11 PM ET
Size
5.4 KB
Accession
0001213900-18-009315
Insider Transaction Report
Form 4
O'Loughlin Steve
Chief Financial Officer
Transactions
- Award
Options to purchase common stock
2018-07-13$0.78/sh+265,000$207,469→ 265,000 totalExercise: $0.78From: 2018-07-13Exp: 2028-07-13→ Common Stock (265,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001615840
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:11 PM ET
- Size
- 5.4 KB